Document Detail


Post-prandial intragastric and duodenal acidity are increased in patients with chronic pancreatitis.
MedLine Citation:
PMID:  10383529     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Patients with chronic pancreatitis and exocrine insufficiency have lower intraduodenal pH compared to controls. It has been assumed that abnormal low intraduodenal pH in these patients not only results from impaired pancreatic bicarbonate secretion but also from an increased gastric acid load to the duodenum. METHODS: We have tested this hypothesis by combined intragastric and intraduodenal 24 h pH monitoring in nine chronic pancreatitis patients with exocrine pancreatic insufficiency and nine healthy control subjects during standardized test conditions. Postprandial gastrin and cholecystokinin release were also determined. RESULTS: Median 24-h intraduodenal pH (5.90 vs. 6.00) and intragastric pH (1.60 vs. 1.70) were not significantly different between patients and controls. However, in the 2-h postprandial periods intraduodenal pH was below five for a significantly higher percentage of time in chronic pancreatitis patients compared to controls (lunch: 14.5% vs. 0.17%, P=0.011; dinner: 24.1% vs. 5.75%, P=0.05). The post-dinner intragastric pH was below three for a significantly higher percentage of time in chronic pancreatitis patients vs. controls (72.2 vs. 48.9%, P=0.04). Postprandial gastrin release was not significantly different between the two groups. Postprandial secretion of cholecystokinin (CCK), as enterogastrone, was significantly (P < 0.01) reduced in chronic pancreatitis patients (78 +/- 13 pmol/L, 120 min) compared to controls (155 +/- 14 pmol/L, 120 min). CONCLUSIONS: Median intraduodenal and intragastric pH are not significantly decreased in patients with chronic pancreatitis and exocrine insufficiency but the postprandial time with an acidic pH in the duodenum (pH < 5) and in the stomach (pH < 3) is significantly (P </= 0.05) increased.
Authors:
W P Geus; E H Eddes; H A Gielkens; K H Gan; C B Lamers; A A Masclee
Related Documents :
1985009 - Pressure measurements from biliary and pancreatic segments of sphincter of oddi. compar...
3605859 - Biliary enteric bypass for benign and malignant disease.
12170409 - Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duc...
3646149 - Electroretinographic examination and definition of serum zinc levels in patients with c...
8554129 - Pitfalls of distal pancreatectomy for relief of pain in chronic pancreatitis.
11054199 - Are diagnostic testing and admission rates higher in non-english-speaking versus englis...
18668599 - Development and validation of a preliminary definition of minimal disease activity in p...
23025269 - New biomarker for neovascular age-related macular degeneration: eotaxin-2.
2798729 - Delusions of fatal contagion among refugee patients.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  13     ISSN:  0269-2813     ISO Abbreviation:  Aliment. Pharmacol. Ther.     Publication Date:  1999 Jul 
Date Detail:
Created Date:  1999-08-19     Completed Date:  1999-08-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  937-43     Citation Subset:  IM    
Affiliation:
Department of Intensive Care, Leyenburg Hospital, The Hague, The Netherlands; Department of Gastroenterology-Hepatology, Leiden University Medical Center, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Case-Control Studies
Cholecystokinin / blood
Chronic Disease
Duodenum / metabolism*,  secretion
Exocrine Pancreatic Insufficiency / blood,  metabolism*
Female
Gastric Mucosa / metabolism*
Gastrins / blood
Humans
Hydrogen-Ion Concentration
Male
Middle Aged
Pancreatitis / blood,  metabolism*
Postprandial Period*
Time Factors
Chemical
Reg. No./Substance:
0/Gastrins; 9011-97-6/Cholecystokinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Altered oesophageal motility following the administration of the 5-HT1 agonist, sumatriptan.
Next Document:  A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation?